Jove
Visualize
联系我们

相关概念视频

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

496
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
496
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

196
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
196
Dementia01:30

Dementia

117
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
117

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Revolutionizing Transcriptomics: From Single-Cell Insights to RNA-based Interventions.

SLAS technology·2026
Same author

A robust direction of arrival estimation method based on the chaotic MUSIC algorithm.

Scientific reports·2026
Same author

Electrically Reconfigurable Floating Gate Optoelectronic Synaptic Pixels for In-sensor Convolutional Image Feature Extraction with Built-in Contrast Enhancement.

ACS nano·2026
Same author

Precision Biomarker Identification in Gynecological Cancers Using Coexpression Networks and Attention-Based LSTM in Healthcare 4.0.

Diagnostics (Basel, Switzerland)·2026
Same author

Impact of Contact Gating on Scaling of Monolayer 2D Transistors Using a Symmetric Dual-Gate Structure.

ACS nano·2026
Same author

Multimodal fusion and explainability of artificial intelligence models in Alzheimer's Disease detection.

Brain informatics·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jul 11, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K

可解释的基于人工智能的阿尔茨海默病预测和管理,使用多式联络数据.

Sobhana Jahan1,2, Kazi Abu Taher2, M Shamim Kaiser3

  • 1Department of Computer Science and Engineering, Bangladesh University of Professionals, Dhaka, Bangladesh.

PloS one
|November 16, 2023
PubMed
概括

这项研究引入了一种可解释的机器学习模型,用于使用多式联络数据诊断阿尔茨海默病. 随机森林模型实现了98.81%的准确性,提高了对阿尔茨海默病预测的信任和性能.

更多相关视频

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.9K

相关实验视频

Last Updated: Jul 11, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.9K

科学领域:

  • 神经科学是一个神经科学.
  • 人工智能的人工智能
  • 医疗信息学 医疗信息学

背景情况:

  • 痴呆症,包括阿尔茨海默病,是全球死亡和残疾的主要原因.
  • 目前用于阿尔茨海默氏症诊断的机器学习模型由于其黑盒性质而缺乏信任,并且通常仅依赖神经成像数据.
  • 需要对阿尔茨海默氏症的诊断工具进行改进和解释.

研究的目的:

  • 通过使用多式联络数据集,提出一种新的,可解释的阿尔茨海默病预测模型.
  • 通过结合临床,MRI细分和心理数据来解决现有模型的局限性.
  • 推进对阿尔茨海默氏症多式联络五类分类的理解.

主要方法:

  • 利用九个流行的机器学习模型,包括随机森林 (RF),物流回归 (LR) 和支持矢量机器 (SVM),进行五类分类.
  • 进行了临床,MRI细分和心理数据的数据级融合.
  • 为了模型的可解释性,使用了夏普利添加式解释 (SHAP).

主要成果:

  • 随机森林分类器实现了10倍的交叉验证准确率98.81%,用于分类阿尔茨海默氏症,认知正常,非阿尔茨海默氏症痴呆症,不确定的痴呆症等.
  • 使用SHAP的可解释AI (XAI) 提供了对预测推理的见解.
  • 这项研究是第一个使用OASIS-3数据集对阿尔茨海默病进行多模式五类分类的研究.

结论:

  • 开发的可解释的人工智能模型在预测阿尔茨海默氏病方面表现出高准确性和可靠性.
  • 多模式数据融合显著提高了阿尔茨海默病的诊断能力.
  • 提出了一种新的阿尔茨海默病患者管理架构,为改善患者护理提供了潜力.